HeMo Bioengineering Pte. Ltd. Sustainability Profile
HeMo Bioengineering Pte. Ltd., commonly referred to as HeMo Corp, is a pioneering company headquartered in Singapore (SG) that operates at the forefront of the bioengineering industry. Founded in 2015, HeMo has rapidly established itself as a leader in developing innovative biotechnological solutions, particularly in the fields of regenerative medicine and tissue engineering. With a strong focus on creating advanced biomaterials and cellular therapies, HeMo's core products are distinguished by their unique ability to enhance healing processes and improve patient outcomes. The company has achieved significant milestones, including collaborations with leading research institutions and successful product launches that have garnered attention in the global market. HeMo Bioengineering continues to solidify its position as a key player in the bioengineering sector, committed to advancing healthcare through cutting-edge technology and research.
DitchCarbon Score
How does HeMo Bioengineering Pte. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HeMo Bioengineering Pte. Ltd.'s score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HeMo Bioengineering Pte. Ltd.'s reported carbon emissions
HeMo Bioengineering Pte. Ltd., headquartered in Singapore (SG), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that HeMo Bioengineering may still be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions profile. As the company operates within the bioengineering sector, it is essential for HeMo Bioengineering to consider establishing clear climate commitments and reduction targets to align with industry standards and expectations. This could include setting science-based targets to reduce emissions across all scopes (Scope 1, 2, and 3) and participating in initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) to enhance transparency and accountability in its environmental impact.
How Carbon Intensive is HeMo Bioengineering Pte. Ltd.'s Industry?
How Carbon Intensive is HeMo Bioengineering Pte. Ltd.'s Location?
HeMo Bioengineering Pte. Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
HeMo Bioengineering Pte. Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
